| NRIX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NRIX shares outstanding history going back to 7/24/2020:
Also see: NRIX Market Cap History NRIX YTD Return |
NRIX Shares Outstanding History — Nurix Therapeutics Share Count Over Time
As of 6/30/2026 Nurix Therapeutics has 103.78 million NRIX shares outstanding. Investors often track the NRIX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NRIX share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 7/24/2020.
| NRIX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
NRIX Historical Shares Outstanding: +20.18% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| NRIX Stock Price Chart |
| About Nurix Therapeutics Inc |
| Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. We show 24 historical shares outstanding datapoints in our coverage of NRIX's shares outstanding history. Understanding the changing numbers of NRIX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NRIX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NRIX by allowing them to research NRIX shares outstanding history as well as any other stock in our coverage universe. |
| NRIX Current Stock Quote |
Quotes delayed 20 minutes  Free NRIX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NRIX Share Performance |
| Shares Outstanding Peers |
| Nurix Therapeutics (NRIX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NRXP Shares Outstanding History NSPR Shares Outstanding History NSTG Shares Outstanding History NTEC Shares Outstanding History NTGN Shares Outstanding History NTHI Shares Outstanding History NTLA Shares Outstanding History NTRA Shares Outstanding History NTRB Shares Outstanding History NTUS Shares Outstanding History More Healthcare companies » |
NRIX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
